What the condition is
Onychomycosis is a fungal infection of the nail unit, most often caused by dermatophytes, sometimes by yeasts or non-dermatophyte moulds. It produces thickening, yellow-brown or white discolouration, crumbling at the free edge, separation of the nail plate from the nail bed, and in advanced cases a nail that is painful in a shoe. It becomes commoner with age, and is more frequent and more consequential in people with diabetes or reduced circulation. The NHS overview of fungal nail infection is a reasonable general description; the StatPearls review of onychomycosis hosted by the National Center for Biotechnology Information covers the clinical detail.
One thing worth establishing before any treatment: a discoloured, thickened nail is not necessarily fungal. Nail psoriasis, chronic trauma from footwear, lichen planus, bacterial colonisation and, rarely, malignancy can look similar. Confirming the diagnosis — by clippings sent for microscopy and culture, or by PCR — matters, because treating a non-fungal nail as fungal wastes months.
What laser devices are cleared to do
This is the crux, and it is routinely misstated. In the United States, laser devices marketed for this purpose have generally been cleared for the temporary increase in clear nail in people with onychomycosis. That phrase is precise and it is narrow. It is not a clearance for curing the infection, for eradicating the organism, or for producing a permanent result. A clearance of that kind means the device was permitted to market on the basis of showing a temporary cosmetic improvement, which is a considerably lower bar than demonstrating mycological cure.
Marketing copy for these devices has often blurred that distinction, describing lasers as killing the fungus, being free of side effects, or clearing nails in a fixed small number of sessions. Those claims go beyond what the clearance covers and, in most cases, beyond what the published trials support.
What the trials actually found
The published evidence base is smaller and weaker than the volume of marketing suggests. Trials have tended to be small, short, industry-associated, and inconsistent in how they define success — some report on the appearance of the nail, some on whether fungus can still be cultured from it, and those two measures can diverge sharply. Studies reporting good cosmetic improvement have frequently reported much lower rates of true mycological cure at the same time point.
The honest summary is that laser treatment can improve how a nail looks in a proportion of people, that the effect is often partial and not always durable, and that it has not been shown to match the mycological cure rates achieved by systemic antifungal therapy. Reviews of the field have repeatedly called for larger, longer, independent trials with standardised outcome measures — which is the polite way of saying the current evidence cannot settle the question.
Why it is attractive anyway
The appeal is real and worth stating fairly. Oral antifungals are effective but require a course of several months, carry a small risk of liver effects, need consideration of drug interactions, and are not suitable for everyone. Topical antifungals are safe but penetrate the nail plate poorly and have modest cure rates over long courses. Against that, a treatment that involves no drug, no blood monitoring and no systemic exposure is understandably appealing — particularly for someone who cannot take the oral option.
That is a legitimate reason to consider laser treatment. It is not a reason to believe it works better than it does.
Practical questions worth asking
- Has the diagnosis been confirmed? If nail clippings have not been tested, the first question is whether the nail is fungal at all.
- What outcome is being promised? Ask specifically whether the expected result is cosmetic improvement or mycological cure, and how it will be measured.
- What happens if the nail relapses? Reinfection is common whatever the treatment, because the reservoir is often in the skin and the shoes.
- What is the total cost? These treatments are usually not covered by insurance, courses are multi-session, and the cost is generally borne by the patient.
- What are the alternatives in my case? Including the option of doing nothing, which is entirely reasonable for an asymptomatic nail in an otherwise healthy person.
The parts nobody markets
Whatever the treatment, nails grow slowly. A great toenail takes roughly twelve to eighteen months to replace itself completely, so any judgement about whether a treatment worked is a judgement made a year later, not a month later. Recurrence rates after apparently successful treatment are substantial across all modalities. And treating the nail without addressing the skin — athlete's foot between the toes, footwear that stays damp, shared floors — invites the infection straight back.
When this stops being cosmetic
For most people a fungal nail is a nuisance. For some it is not. If you have diabetes, peripheral neuropathy, peripheral arterial disease, or any condition that suppresses immunity, a fungal nail is a break in the foot's defences and a potential route to cellulitis or ulceration. In that situation this is not a cosmetic question and it should be assessed rather than managed at home — see the diabetic foot.
Also worth an assessment: a single dark or pigmented streak in one nail, a nail that is painful rather than merely ugly, surrounding skin that is red, warm or swollen, or a nail change that started after an injury and is not growing out.
Related reading on this site: ingrown toenails and nail disorders, and when a foot problem needs professional care.